Last Update Time:
05-Mar-2025 16:00:00
ISIN:
INE727B01026
Sector:
Information Technology
Symbol:
GENESYS
Genesys International Corporation Limited
₹724.30
₹54.80
(8.19%)
▲
Prev. Close
₹669.50
Open
₹665.35
Close
₹724.90
Range
₹688.09 - ₹760.52
High
₹737.15
Low
₹665.35
Ind. Close
₹0.00
VWAP
₹714.65
The current stock price of Genesys International Corporation Limited is ₹724.30, with a target price range between ₹688.09 and ₹760.52. The stock has experienced a price change of ₹54.80 (8.19%), reflecting recent market volatility.
Today's opening price was ₹665.35, while the previous close stood at ₹669.50.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Genesys International Corporation Limited Price Chart
Genesys International Corporation Limited Pre Open Market Overview: 05-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 665.35
- Previous Close Price: 669.5
- Change: -4.15%
- Total Traded Volume: 557
- Total Buy Quantity: 9,148
- Total Sell Quantity: 13,448
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 661.00 | 150.00 | 0.00 |
| 663.00 | 1,000.00 | 0.00 |
| 664.00 | 1,000.00 | 0.00 |
| 665.00 | 100.00 | 0.00 |
| 665.35 | 243.00 | 0.00 |
| 669.00 | 0.00 | 2.00 |
| 670.00 | 0.00 | 400.00 |
| 671.00 | 0.00 | 1,226.00 |
| 672.00 | 0.00 | 300.00 |
| 673.00 | 0.00 | 100.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 9148
Total Sell Quantity: 13448
Shareholding Patterns of Genesys International Corporation Limited
Key Trade Statistics of Genesys International Corporation Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 3.99 |
| Traded Value (₹ Cr.) | 28.52 |
| Total Market Cap (₹ Cr.) | 2,882.88 |
| Free Float Market Cap (₹ Cr.) | 1,802.87 |
| Impact cost | 0.09 |
| Quantity Traded | 399,018.00 |
| Deliverable Quantity | 133,817.00 |
| % of Quantity to Traded | 33.54 |
| Security VaR | 25.32 |
| Index VaR | N/A |
| VaR Margin | 25.32 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 28.82 |
| Face Value | 5 |
Key Price Statistics of Genesys International Corporation Limited
The 52-week high for Genesys International Corporation Limited was ₹1,055.00, recorded on 20-Jan-2025. On the other hand, the 52-week low stands at ₹420.55, with the lowest value recorded on 04-Jun-2024.
The upper band for trading is ₹803.40, and the lower band is ₹535.60. The price band is 20%.
The stock's daily volatility stands at 3.76, while the annualized volatility is 71.83. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (20-Jan-2025) | 1,055.00 |
| 52 Week Low (04-Jun-2024) | 420.55 |
| Upper Band | 803.40 |
| Lower Band | 535.60 |
| Price Band (%) | 20 |
| Daily Volatility | 3.76 |
| Annualised Volatility | 71.83 |
| Tick Size | 0.05 |
Key Securities Statistics of Genesys International Corporation Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 23-Jan-2003 |
| Adjusted P/E | 51.35 |
| Symbol P/E | 51.35 |
| Index | NA |
| Macro-Economic Sector | Information Technology |
| Sector | Information Technology |
| Industry | IT - Services |
| Basic Industry | IT Enabled Services |
Security Status of Genesys International Corporation Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Genesys International Corporation Limited
| Subject | Date |
|---|---|
| Shareholders meeting | 04-Mar-2025 |
| Copy of Newspaper Publication | 19-Feb-2025 |
| Notice Of Shareholders Meetings-XBRL | 18-Feb-2025 |
| Shareholders meeting | 18-Feb-2025 |
| Copy of Newspaper Publication | 16-Feb-2025 |
| Integrated Filing- Financial | 14-Feb-2025 |
| Press Release | 14-Feb-2025 |
| Outcome of Board Meeting | 14-Feb-2025 |
Corporate Actions of Genesys International Corporation Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 5 | Annual General Meeting | 23-Sep-2024 |
| 5 | Annual General Meeting | 21-Sep-2023 |
| 5 | Annual General Meeting | 22-Sep-2022 |
| 5 | Annual General Meeting | 22-Sep-2021 |
| 5 | Annual General Meeting | 18-Sep-2020 |
| 5 | Annual General Meeting/Dividend - Rs.0125 Per Share | 18-Sep-2019 |
| 5 | Annual General Meeting/Dividend- Re 0.125 Per Share | 18-Sep-2018 |
| 5 | Annual General Meeting/Dividend - Re 0.125 Per Share | 19-Sep-2017 |
| 5 | Annual General Meeting And Dividend Re.0.125 Per Share | 21-Sep-2016 |
| 5 | Annual General Meeting/Dividend Re 0.125 Per Share | 18-Sep-2015 |
| 5 | Annual General Meeting / Dividend - Re 0.125/- Per Share | 18-Sep-2014 |
| 5 | Annual General Meeting And Dividend Re.0.25 Per Share | 11-Sep-2013 |
| 5 | Annual General Meeting And Dividend - Rs.1.25 Per Share | 06-Sep-2012 |
| 5 | Annual General Meeting And Dividend Rs.1.25 Per Share | 17-Aug-2011 |
| 5 | Annual General Meeting And Dividend Re.0.75 Per Share | 06-Sep-2010 |
| 5 | Face Value Split From Rs.10/- To Rs.5/- | 23-Jun-2010 |
| 5 | Int Div-Re.1/- Per Share | 10-May-2010 |
| 5 | Agm/Div-Rs.2/- Per Share | 22-Sep-2009 |
| 5 | Agm/Dividend - 20% | 24-Sep-2008 |
| 5 | Agm | 23-Nov-2007 |
Board Meetings of Genesys International Corporation Limited
Financial Results of Genesys International Corporation Limited
Company Directory of Genesys International Corporation Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.igenesys.com | Registered Office | 73-A, SDF-III SEEPZ, Andheri (East) |
MUMBAI |
| www.igenesys.com | Transfer Agent | M/s Bigshare Services Private Limited E-2/3, Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri(E), |
MUMBAI |
Insider Trading of Genesys International Corporation Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Sajid Malik | 213112626 | Pledge Revoke |
| 7(2) | Saroja Malik | 202469895 | Pledge Revoke |
| 7(2) | SUDHA GANAPATHY | 29822898 | Sell |
| 7(2) | SUDHA GANAPATHY | 36175913 | Sell |
| 7(2) | SUDHA GANAPATHY | 60563962 | Sell |
| 7(2) | Vineet Chopra | 917963 | Buy |
| 7(2) | Vineet Chopra | 760833 | Buy |
| 7(2) | GANAPATHY VISHWANATHAN | 300000000 | Sell |
| 7(2) | Tukaram Ature | 1218577 | Sell |
| 7(2) | Shanazir Shaikh | 1609720 | Sell |
| 7(2) | Mrs. Mala Acharya (wife of Mr. Ganesh Acharya) | 2059220 | Sell |
| 7(2) | Sagar Patil | 1100750 | Buy |
| 7(2) | Vineet Chopra | 1871275 | Buy |
| 7(2) | Milind kshirsagar | 2641800 | Buy |
| 7(2) | Lokendra J Koria | 2641800 | Buy |
| 7(2) | Sandesh Kavatkar | 2641800 | Buy |
| 7(2) | Vivek Shetty | 5944050 | Buy |
| 7(2) | Rehan Ansari | 1629110 | Buy |
| 7(2) | Kaustubh Chandorkar | 1320900 | Buy |
| 7(2) | Vasim Mukkadam | 2241264 | Buy |
Annual Reports of Genesys International Corporation Limited
Investor Complaints of Genesys International Corporation Limited
Event Calendar of Genesys International Corporation Limited
| Purpose | Details |
|---|---|
| Demerger | To discuss, evaluate and approve the Company's plans for de-merger of its information Technology and Engineering business unit and share swap ratio. |
| Results/Dividend | Interalia, to consider and decide the following; (1)To approve the Annual Accounts and Audited Financial Results of the Company for the year ended March 31, 2010 (2)To recommend Dividend, if any, on equity shares of the Company for the year ended March 31, 2010. |
| Amalgamation/Merger | Interalia, to consider the amalgamation of Genesys Worldeye Limited (a 100% Wholly Owned Subsidiary Company) with the Company, pursuant to the provisions of Section 391 to 394 of the Companies Act, 1956. |
| Raising of Funds | Interalia, to consider the following : (1) Increase in Borrowing Powers of the Company to Rs.400 Crore; and (2) Raising of additional funds by way of issue of QIP/FCCB/ADR/GDR or through any mode of securities to the extent of Rs. 350 Crore, subject to approval of shareholders of the Company and other regulatory authorities. |
| Results/Dividend | Interalia, to consider and decide the following: (1)To approve the Annual Accounts and Audited Financial Results of the Company for the year ended March 31, 2011 (2)To recommend Dividend, if any, on Equity shares of the Company for the year ended March 31, 2011. |
| Results/Dividend | Interalia, to consider and decide the following : (1) To consider and approve the Annual Accounts and Audited Financial Results of the Company for the year ended March 31, 2012; (2) To consider recommendation of dividend, if any, on the Equity Shares of the Company for the year ended March 31, 2012. |
| Results | Interalia, to consider, approve and take on record the Un-audited Financial Results of the Company for the Third Quarter ended December 31, 2012. |
| Results/Dividend | Interalia, to consider and decide the following : (1) To consider and approve the Annual Accounts and Audited Financial Results of the Company for the year ended March 31, 2013; (2) To consider recommendation of dividend, if any, on the Equity Shares of the Company for the year ended March 31, 2013. |
| Results | Interalia, to consider, approve and take on record the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2013. |
| Preferential issue | inter alia, to consider the following: - To discuss and approve further issue of Shares / Securities/Warrants convertible into Equity Shares of the Company under section 81(1A) of the Companies Act, 1956 by way of Preferential Issue as per Chapter VII of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009, as amended and other applicable rules, regulations and guidelines of SEBI, subject to the approval of members of the Company. |
| Results | Interalia, to discuss and take on record the Un-audited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2013. |
| Results | Interalia, to discuss, approve and take on record the Un-audited Financial Results of the Company for the Third Quarter ended December 31, 2013. |
| Results/Dividend | Interalia, to consider and decide the following : (1) To consider and approve the Annual Accounts and Audited Financial Results of the Company for the year ended March 31, 2014; (2) To consider recommendation of dividend, if any, on the Equity Shares of the Company for the year ended March 31, 2014. |
| Results | Inetr alia , to discuss and take on record the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2014 |
| Results | Inter alia , to discuss and take on record the Un-audited Financial Results of the Company for the Second Quarter and half year ended September 30, 2014. |
| Results | Inter alia , to discuss and take on record the Un-audited Financial Results of the Company for the Third Quarter ended December 31, 2014. |
| Results/Dividend | Interalia, to consider and decide the following: 1. To consider and approve the Annual Accounts and Audited Financial Results of the Company for the year ended March 31, 2015. 2. To consider recommendation of dividend, if any, on the Equity Shares of the Company for the year ended March 31, 2015. |
| Results | interalia, to discuss and take on record the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2015. |
| Results | Interalia, to discuss and take on record the Un-audited Financial Results of the Company for the Second Quarter and Half Year ended September 30, 2015. |
| Results | Interalia, to discuss and take on record the Un-audited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2015. |
| Results/Dividend | Interalia, to decide the following :1. To consider and approve the Annual Accounts and Audited Financial Results of the Company for the Financial Year Ended March 31, 2016.2. To consider recommendation of dividend, if any, on the Equity Shares of the Company for the financial year ended March 31, 2016. |
| Results | Interalia, to discuss and take on record the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2016. |
| Board meeting Rescheduled | GENESYS : 13-Aug-2016 : The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held August 11, 2016, Interalia, to discuss and take on record the Un-audited Financial Results of the Company for the First Quarter ended June 30, 2016. The Company has now informed the Exchange that the meeting of the Board of Directors has now been postponed to August 13, 2016(Revised). |
| Results | inter - alia, to discuss and take on record the un-audited Financial Results of the Company for the second Quarter and half Year ended September 30, 2016. |
| Results | Inter alia, to approve and take on record the Un-audited Financial Results of the Company for the Third Quarter and Nine Months ended December 31, 2016. |
| Results/Dividend | inter alia, to consider and approve the Annual Accounts and Audited Financial Results of the Company and recommendation of Dividend on Equity Shares of the Company, if any, for the financial year ended March 31, 2017. Further, in terms of the Company s Code of Conduct to regulate, monitor and report trading by Insiders adopted by the Company, the trading window for dealing in Company s shares shall remain closed from May 23, 2017 till the expiry of 48 hours after publication of Audited Financial results for the financial year ended March 31, 2017. |
| Results | inter alia, to discuss and take record the Un-audited Financial Results of the Company for the first quarter ended on June 30, 2017. |
| Results | inter - alia, to discuss and take on record the un-audited Financial Results of the Company for the second Quarter and half Year ended September 30, 2017. |
| Results | inter alia , to discuss and take on record the Un-audited Financial Results of the Company for the third quarter ended on December 31, 2017. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend on equity shares, if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2019 |
| Financial Results | Intimation of Board Meeting to approve the un-audited financial results for the third quarter ended December 31, 2019. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2020 and dividend |
| Financial Results | Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Friday, July 31, 2020, to inter alia, consider and approve the unaudited (standalone and consolidated) financial results of the Company for the quarter ended June 30, 2020. |
| Financial Results | Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, November 03, 2020, inter alia , to consider and approve the un audited (standalone and consolidated) financial results of the Company for the second quarter ended September 30, 2020. |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2020 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Fund Raising/Other business matters | This is to inform you that pursuant to Regulation 29 (1) (d) and other applicable provision of SEBI Listing Regulations, a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, 6th July, 2021 to inter-alia consider and approve following business:a. Proposal to raise funds by issuance of securities i.e. Equity and /or unsecured compulsorily convertible debentures and/ or warrants and / or other securities of the Company on a preferential basis subject to approval of members of the Company and in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, the Companies Act, 2013 and other applicable rules, regulations and guidelines. b. Proposal to seek shareholder s approval on aforesaid matter by calling an Extraordinary General Meeting. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results | Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Tuesday, October 26, 2021, inter alia, to consider and approve the un-audited (standalone and consolidated) financial results of the Company for the quarter and half year ended September 30, 2021. |
| Financial Results | Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the meeting of the Board of Directors of the Company will be held on Monday, February 14, 2022, to inter alia, consider and approve the unaudited (standalone and consolidated) financial results of the Company for the quarter and nine months ended December 31, 2021. |
| Financial results | Genesys International Corporation Limited has informed the Exchange about meeting of the Board of Directors of the Company to be held at Registered Office on Monday, May 30, 2022, to inter alia consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2022. |
| Financial results | Genesys International Corporation Limited has informed the Exchange that in compliance with the regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations ,2015, this is to inform you that the meeting of Board of Directors of the Company which was scheduled to be held today on 30th May 2022 to consider and approve inter-alia the audited standalone and consolidated financial results for the quarter and financial year ended 31st March 2022 has been postponed due to non-availability of certain information from overseas subsidiary due to Corona Virus (Covid 19).Now, the Board Meeting is scheduled to be held on Tuesday ,7th June 2022 You are requested to take the above on your records. |
| Financial results | Genesys International Corporation Limited has informed the Exchange about Board Meeting to be held on 12-Aug-2022 to consider financial results (standalone and consolidated) for the period ended June 2022 |
| Financial results | Genesys International Corporation Limited has informed the Exchange that a meeting of the Board of Directors of the Company will be held on Monday, November 14, 2022, to inter alia consider and approve the un-audited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2022. |
| Other business matters | This is to inform you that the meeting of the Board of Directors of the Company will beheld on 19th December, 2022, to consider and approve the scheme of amalgamation /merger of Virtual World Spatial Technologies Private Limited (VWSTPL) a whollyowned subsidiary, ('Transferor Company'), with Genesys International CorporationLimited (GICL) ('Transferee Company'As per the Company￢ﾀﾙs Code of Conduct framed under the SEBI (Prohibition of InsiderTrading) Regulations, 2015, the trading window for dealing in securities of the Companyshall remain closed for all Designated Persons and their immediate Relatives fromDecember 16 2022 till the expiry of 48 hours after outcome of the Board meeting isdeclared. |
| Financial Results | Intimation of Board Meeting to approve the un-audited financial results for the quarter and nine months ended December 31, 2022 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
| Financial Results | Intimation of Board Meeting to approve the un-audited financial results for the quarter ended June 30, 2023 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2023 |
| Financial Results/Other business matters | GENESYS INTERNATIONAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2024 to consider and approve the Audited Financial results of the Company for the quarter and financial year ended 31-March-2024 and Other business |
| Financial Results | GENESYS INTERNATIONAL CORPORATION LIMITED has informed the Exchange about Board Meeting to be held on 14-Aug-2024 to consider and approve the Un-audited Financial results of the Company for the period ended June 2024 and Other business. |
| Financial Results | To consider and approve the financial results (standalone and consolidated) for the quarter and half year ended September 30, 2024. |
| Financial Results/Fund Raising/Other business matters | To consider and approve the financial results for the period ended December 31, 2024, Fund Raising and other business matters |
Share Transfers of Genesys International Corporation Limited
Voting Results of Genesys International Corporation Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 03-MAR-2025 | Postal Ballot | Appointment of Mr. Ajay Harish Aggarwal (DIN: 02437996) as a Non-ExecutivenIndependent Directorn |
| 30-SEP-2024 | AGM | Adoption of Accounts (Standalone and Consolidated), Report of the Auditors and Directors Thereon |
| 30-SEP-2024 | AGM | Reappointment of Dr. Yogita Shukla who retires by rotation and being eligible offers herself for reappointment |
| 13-JUN-2024 | Postal Ballot | Appointment of Dr. Yogita Shukla (Din No.09286545) as a Non-Executive Non Independent Director |
| 13-JUN-2024 | Postal Ballot | Material Related Party Transaction with A. N. Virtual World Tech Limited, Cyprus, a subsidiary company |
| 13-JUN-2024 | Postal Ballot | Appointment of Mr. Omprakash Hemrajani (Din No.07976475) as a Non-Executive Non Independent Director |
| 28-SEP-2023 | AGM | Adoption of the Audited financial statements ￢ﾀﾓ Standalone and Consolidated - of the Company for the financial year ended 31st March, 2023 together with the Directors￢ﾀﾙ Report and Auditors￢ﾀﾙ Report thereonn |
| 28-SEP-2023 | AGM | Retirement by rotation of Mr. Ganapathy Vishwanathan, Non-Executive Director and not to fill the vacancy so created |
| 30-SEP-2022 | AGM | Adoption of the Audited Financial Statements (Standalone & Consolidated) of the Company for the financial year ended March 31, 2022 together with Reports of the Auditors and Directors thereon. |
| 30-SEP-2022 | AGM | Grant of Stock Options to the employees of Subsidiary, Associates & Joint Venture Company/ ies under ￢ﾀﾜGENESYS ESOP SCHEME - 2022￢ﾀﾝ |
| 30-SEP-2022 | AGM | To approve Material Related Party Transaction(s). |
| 30-SEP-2022 | AGM | To approve remuneration to Non-Executive Directors (including Independent Directors). |
| 30-SEP-2022 | AGM | Appointment of Ms. Bharti Sinha (DIN: 07985813) as Non-Executive Independent Director. |
| 30-SEP-2022 | AGM | Re-appointment of Mrs. Saroja Malik (DIN: 00400421) as Whole-time Director. |
| 30-SEP-2022 | AGM | Re-appointment of Mr. Sajid Malik (DIN: 00400366) as Managing Director. |
| 30-SEP-2022 | AGM | Re-appointment of M/s MSKA & Associates, Chartered Accountants, (FRN: 105047W) as Statutory Auditors of the Company. |
| 30-SEP-2022 | AGM | Re-appointment of Mrs. Saroja Malik, Director of the Company who retires by rotation and being eligible, seeks re-appointment. |
| 09-JUL-2022 | EGM | RAISING OF FUNDS THROUGH ISSUE OF EQUITY SHARES ON PREFERENTIALnALLOTMENT BASIS TO THE FOREIGN PORTFOLIO INVESTOR - NON-PROMOTER ￢ﾀﾓnPUBLIC CATEGORY FOR CASH |
| 09-JUL-2022 | EGM | RAISING OF FUNDS THROUGH ISSUE OF WARRANTS CONVERTIBLE INTO EQUITYnSHARES ON PREFERENTIAL ALLOTMENT BASIS TO THE FOREIGN PORTFOLIOnINVESTOR - NON-PROMOTER ￢ﾀﾓ PUBLIC CATEGORY FOR CASH |
| 09-JUL-2022 | EGM | RAISING OF FUNDS THROUGH ISSUE OF EQUITY SHARES ON PREFERENTIALnALLOTMENT BASIS TO THE INDIVIDUAL INVESTORS - NON-PROMOTER ￢ﾀﾓ PUBLICnCATEGORY FOR CASH |
FAQs on Genesys International Corporation Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.